SCHEMBL19100908

SCHEMBL19100908

[2H]C([2H])([2H])c1cc(S(F)(F)(F)(F)F)cc2c1O[C@H](C(F)(F)F)C=C2

nearest known ligand 0.44

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 14/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16893758 0.90 PTGS2 (0.53) PTGS2
SCHEMBL16893648 0.78 PTGS2 (0.57) PTGS2
SCHEMBL19097649 0.72 PTGS2 (0.84) PTGS2
SCHEMBL5566588 0.70 PTGS2 (0.50) PTGS2
SCHEMBL16893933 0.70 PTGS2 (0.51) PTGS2
SCHEMBL5565897 0.65 PTGS2 (0.35) PTGS2
SCHEMBL5566105 0.64 PTGS2 (0.35) PTGS2
SCHEMBL5559994 0.64 PTGS2 (0.50) PTGS2
SCHEMBL7847151 0.63 — —
SCHEMBL16893618 0.61 PTGS2 (1.00) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3400218-A1 COMBINATION OF A CHROMENE COMPOUND AND A SECOND ACTIVE AGENT Euclises Pharmaceuticals, Inc. (US) 2018-11-14 — — EP claimed
WO-2017120591-A1 COMBINATION OF A CHROMENE COMPOUND AND A SECOND ACTIVE AGENT Euclises Pharmaceuticals, Inc. (US) 2017-07-13 — — WO claimed
Send feedback